Tapewire

Nasdaq · USD

SHPH

Shuttle Pharmaceuticals Holdings, Inc.

Export transactions ↓
Tapewire entity
8505
SEC CIK
0001757499
Parsed reports
56

Last 12 months

Inside the activity.

6 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202620
Jul 202645
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 14, 2026 Filed Jul 15, 2026 19:36 UTC SaleCommon Stock 82,116 $4.48 $367,879.68
Disclosure

SEC source: 0001475597-26-000159 · primary_doc.xml · nonDerivative · entry 2

HRT FINANCIAL LP · CIK 0001475597 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
July 13, 2026 Filed Jul 15, 2026 19:36 UTC SaleCommon Stock 1,033 $4.67 $4,824.11
Disclosure

SEC source: 0001475597-26-000159 · primary_doc.xml · nonDerivative · entry 1

HRT FINANCIAL LP · CIK 0001475597 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,238

Read SEC document
July 10, 2026 Filed Jul 13, 2026 18:34 UTC PurchaseCommon Stock 731 $3.11 $2,273.41
Disclosure

SEC source: 0001475597-26-000154 · primary_doc.xml · nonDerivative · entry 2

HRT FINANCIAL LP · CIK 0001475597 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,271

Read SEC document
July 09, 2026 Filed Jul 13, 2026 18:34 UTC PurchaseCommon Stock 8,266 $3.38 $27,939.08
Disclosure

SEC source: 0001475597-26-000154 · primary_doc.xml · nonDerivative · entry 1

HRT FINANCIAL LP · CIK 0001475597 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,540

Read SEC document
July 08, 2026 Filed Jul 9, 2026 21:50 UTC SaleCommon Stock 18,531 $3.52 $65,229.12
Disclosure

SEC source: 0001475597-26-000144 · primary_doc.xml · nonDerivative · entry 2

HRT FINANCIAL LP · CIK 0001475597 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,274

Read SEC document
July 07, 2026 Filed Jul 9, 2026 21:50 UTC SaleCommon Stock 10,580 $3.33 $35,231.40
Disclosure

SEC source: 0001475597-26-000144 · primary_doc.xml · nonDerivative · entry 1

HRT FINANCIAL LP · CIK 0001475597 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,805

Read SEC document
July 06, 2026 Filed Jul 7, 2026 20:23 UTC SaleCommon Stock 9,022 $3.51 $31,667.22
Disclosure

SEC source: 0001475597-26-000138 · primary_doc.xml · nonDerivative · entry 2

HRT FINANCIAL LP · CIK 0001475597 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,385

Read SEC document
July 02, 2026 Filed Jul 7, 2026 20:23 UTC PurchaseCommon Stock 7,851 $3.54 $27,792.54
Disclosure

SEC source: 0001475597-26-000138 · primary_doc.xml · nonDerivative · entry 1

HRT FINANCIAL LP · CIK 0001475597 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,407

Read SEC document
July 01, 2026 Filed Jul 2, 2026 17:37 UTC PurchaseCommon Stock 3,959 $3.30 $13,064.70
Disclosure

SEC source: 0001475597-26-000128 · primary_doc.xml · nonDerivative · entry 1

HRT FINANCIAL LP · CIK 0001475597 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,556

Read SEC document
June 30, 2026 Filed Jul 1, 2026 23:17 UTC PurchaseCommon Stock 6,755 $3.23 $21,818.65
Disclosure

SEC source: 0001475597-26-000123 · primary_doc.xml · nonDerivative · entry 2

HRT FINANCIAL LP · CIK 0001475597 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,597

Read SEC document
June 29, 2026 Filed Jul 1, 2026 23:17 UTC PurchaseCommon Stock 25,836 $3.44 $88,875.84
Disclosure

SEC source: 0001475597-26-000123 · primary_doc.xml · nonDerivative · entry 1

HRT FINANCIAL LP · CIK 0001475597 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,842

Read SEC document
August 08, 2025 Filed Aug 12, 2025 21:22 UTC
Lorber Timothy J.Chief Financial Officer
GrantRestricted Stock Unit · Derivative 24,854 $0.00 $0.00
Disclosure

SEC source: 0001641172-25-023275 · ownership.xml · derivative · entry 2

Lorber Timothy J. · CIK 0002027850 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,854

Underlying: Common Stock · 24,854 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock.

F3 · derivative.exercise_date: These RSUs will vest on 02/08/2026.

F3 · derivative.expiration_date: These RSUs will vest on 02/08/2026.

Read SEC document
August 08, 2025 Filed Aug 12, 2025 21:22 UTC
Lorber Timothy J.Chief Financial Officer
GrantRestricted Stock Unit · Derivative 29,240 $0.00 $0.00
Disclosure

SEC source: 0001641172-25-023275 · ownership.xml · derivative · entry 1

Lorber Timothy J. · CIK 0002027850 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,240

Underlying: Common Stock · 29,240 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock.

F2 · derivative.exercise_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.

F2 · derivative.expiration_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.

Read SEC document
August 08, 2025 Filed Aug 13, 2025 01:48 UTC
Nabyt OlehDirector
GrantRestricted Stock Unit · Derivative 29,240 $0.00 $0.00
Disclosure

SEC source: 0001641172-25-023279 · ownership.xml · derivative · entry 1

Nabyt Oleh · CIK 0002060299 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,240

Underlying: Common Stock · 29,240 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock.

F2 · derivative.exercise_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.

F2 · derivative.expiration_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.

Read SEC document
August 08, 2025 Filed Aug 13, 2025 01:24 UTC GrantRestricted Stock Unit · Derivative 29,240 $0.00 $0.00
Disclosure

SEC source: 0001641172-25-023277 · ownership.xml · derivative · entry 1

Scorsis George · CIK 0002060026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,240

Underlying: Common Stock · 29,240 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock.

F2 · derivative.exercise_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.

F2 · derivative.expiration_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.

Read SEC document
August 08, 2025 Filed Aug 13, 2025 01:23 UTC
Tung JosephDirector
GrantRestricted Stock Unit · Derivative 29,240 $0.00 $0.00
Disclosure

SEC source: 0001641172-25-023276 · ownership.xml · derivative · entry 1

Tung Joseph · CIK 0002060609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,240

Underlying: Common Stock · 29,240 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock.

F2 · derivative.exercise_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.

F2 · derivative.expiration_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.

Read SEC document
August 08, 2025 Filed Aug 13, 2025 12:33 UTC GrantRestricted Stock Unit · Derivative 29,240 $0.00 $0.00
Disclosure

SEC source: 0001641172-25-023376 · ownership.xml · derivative · entry 1

Richards Steven M · CIK 0001945980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,240

Underlying: Common Stock · 29,240 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock.

F2 · derivative.exercise_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.

F2 · derivative.expiration_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.

Read SEC document
December 31, 2024 Filed Feb 3, 2025 19:30 UTC GrantCommon Stock 209,790 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-004732 · ownership.xml · nonDerivative · entry 1

Richards Steven M · CIK 0001945980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,004

F1 · shares: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027.

F2 · balance_after: Consists of (1) 214 shares of common stock and (2) 209,790 RSUs which remain subject to vesting.

Read SEC document
December 31, 2024 Filed Feb 4, 2025 00:30 UTC GrantCommon Stock 209,790 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-004733 · ownership.xml · nonDerivative · entry 1

Schafer Joshua · CIK 0001945557 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,004

F1 · shares: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs which are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027.

F2 · balance_after: Consists of (1) 214 shares of common stock and (2) 209,790 RSUs which remain subject to vesting.

Read SEC document
December 23, 2024 Filed Feb 5, 2025 16:55 UTC
Brown MiltonDirector
GrantCommon Stock 209,790 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-005035 · ownership.xml · nonDerivative · entry 1

Brown Milton · CIK 0001945206 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 346,617

F1 · shares: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs which are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027.

F2 · balance_after: Consists of (1) 135,785 shares of common stock and (2) 210,832 RSUs, which remain subject to vesting.

Read SEC document
December 23, 2024 Filed Feb 6, 2025 19:33 UTC Amendment GrantCommon Stock 209,790 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-005265 · ownership.xml · nonDerivative · entry 1

Richards Steven M · CIK 0001945980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,004

F1 · shares: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027.

F2 · balance_after: Consists of (1) 214 shares of common stock and (2) 209,790 RSUs which remain subject to vesting.

Read SEC document
December 23, 2024 Filed Feb 7, 2025 00:34 UTC Amendment GrantCommon Stock 209,790 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-005267 · ownership.xml · nonDerivative · entry 1

Schafer Joshua · CIK 0001945557 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,004

F1 · shares: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs which are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027.

F2 · balance_after: Consists of (1) 214 shares of common stock and (2) 209,790 RSUs which remain subject to vesting.

Read SEC document
May 01, 2024 Filed Oct 9, 2024 17:00 UTC
Jung MiraChief Scientific Officer
GrantCLASS A COMMON STOCK 598 $11.28 $6,745.44
Disclosure

SEC source: 0001493152-24-040614 · ownership.xml · nonDerivative · entry 1

Jung Mira · CIK 0001945307 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,715

F1 · shares: The Reporting Person received a grant of 1,791 restricted stock units ("RSUs") on May 1, 2023 (14,326 RSUs on a pre-reverse split basis), which RSUs are subject to vesting over a period of three years. The first vesting of 598 RSUs occurred on May 1, 2024.

F2 · balance_after: Consists of (i) 134,522 shares of common stock and (ii) 1,193 RSUs which remain subject to vesting. All share and RSU numbers reflect a 1-for-8 reverse stock split effected by the issuer on August 13, 2024.

Read SEC document
March 08, 2024 Filed Mar 8, 2024 18:18 UTC
Vander Hoek MichaelChief Financial Officer
GrantCOMMON STOCK 100,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-009451 · ownership.xml · nonDerivative · entry 1

Vander Hoek Michael · CIK 0001945351 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,852

Read SEC document
December 13, 2023 Filed Dec 21, 2023 02:51 UTC
Jacobs BetteDirector
SaleCommon Stock 4,157 $0.46 $1,925.52
Disclosure

SEC source: 0001493152-23-045648 · ownership.xml · nonDerivative · entry 1

Jacobs Bette · CIK 0001953668 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,064

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.

F2 · balance_after: Consists of (i) 15,201 shares of common stock and (ii) 11,863 RSUs which remain subject to certain vesting conditions.

Read SEC document
December 13, 2023 Filed Jan 2, 2024 17:10 UTC
Brown MiltonDirector
SaleCommon Stock 2,921 $0.46 $1,353.01
Disclosure

SEC source: 0001493152-24-000125 · ownership.xml · nonDerivative · entry 1

Brown Milton · CIK 0001945206 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,094,610

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.

F2 · balance_after: Consists of (i) 1,077,943 shares of common stock and (ii) 16,667 RSUs which remain subject to certain vesting conditions.

Read SEC document
August 14, 2023 Filed Aug 18, 2023 23:48 UTC
Dritschilo AnatolyDirector · CEO and Chairman · 10% owner
GiftCOMMON STOCK 2,100,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-029472 · ownership.xml · nonDerivative · entry 2

Dritschilo Anatoly · CIK 0001945126 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By PAL Trust

Disclosed balance after: 2,100,000

F3 · balance_after: Consists of 2,100,000 shares gifted by the Reporting Person's spouse to PAL Trust, a trust formed for the benefit of the Reporting Person's adult children and for which a third party serves as external trustee and two of the Reporting Person's children serve as co-trustees. Beneficial ownership is disclaimed except to the extent the Reporting Person's spouse maintains any pecuniary interest therein. The inclusion in this report of the 2,100,000 shares held by the trust for the benefit of the Reporting Person's adult children shall in no way be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
August 14, 2023 Filed Aug 18, 2023 23:48 UTC
Dritschilo AnatolyDirector · CEO and Chairman · 10% owner
GiftCOMMON STOCK 2,100,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-029472 · ownership.xml · nonDerivative · entry 1

Dritschilo Anatoly · CIK 0001945126 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 1,104,407

F1 · shares: Represents 2,100,000 shares held by the spouse of the Reporting Person, and over which the Reporting Person disclaims any beneficial ownership or control. Prior to the contribution, the Reporting Person's spouse held a total of 3,204,407 shares. On August 14, 2023, she contributed 2,100,000 shares to PAL Trust, a trust formed for the benefit of her adult children.

F2 · balance_after: Consists of 1,104,407 shares held by the spouse of the Reporting Person. The inclusion in this report of the 1,104,407 shares held by the Reporting Person's spouse shall in no way be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 08:29 UTC
Brown MiltonDirector
GrantStock Options · Derivative 25,000 $0.00 Strike: $1.92 $0.00
Disclosure

SEC source: 0001493152-23-005375 · ownership.xml · derivative · entry 1

Brown Milton · CIK 0001945206 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Class A Common Stock · 25,000 shares

Expires 2028-02-15

F1 · balance_after: The Reporting Person received 25,000 stock options ("Stock Options") to purchase shares of SHPH common stock on February 15, 2023, which Stock Options vest in full on the first anniversary of the date of grant.

Read SEC document
December 29, 2022 Filed Dec 30, 2022 16:06 UTC
Vander Hoek MichaelChief Financial Officer
SaleCOMMON STOCK 2,243 $1.61 $3,600.02
Disclosure

SEC source: 0001493152-22-037141 · ownership.xml · nonDerivative · entry 1

Vander Hoek Michael · CIK 0001945351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,852

F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6,095 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.

F2 · balance_after: Consists of 3,852 shares of SHPH common stock.

Read SEC document
December 29, 2022 Filed Dec 30, 2022 20:48 UTC
Dritschilo PeterPresident and COO
SaleCOMMON STOCK 3,820 $1.61 $6,131.10
Disclosure

SEC source: 0001493152-22-037210 · ownership.xml · nonDerivative · entry 1

Dritschilo Peter · CIK 0001944900 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,560

F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 10,380 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.

F2 · balance_after: Consists of 6,560 shares of SHPH common stock.

Read SEC document
December 29, 2022 Filed Jan 3, 2023 06:10 UTC
Rich TyvinChief Medical Officer
SaleCOMMON STOCK 1,414 $1.61 $2,269.47
Disclosure

SEC source: 0001493152-23-000014 · ownership.xml · nonDerivative · entry 1

Rich Tyvin · CIK 0001945208 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,429

F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 3,843 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.

F2 · balance_after: Consists of 2,429 shares of SHPH common stock.

Read SEC document
December 29, 2022 Filed Jan 3, 2023 06:10 UTC
Jung MiraChief Scientific Officer
SaleCLASS A COMMON STOCK 328 $1.61 $526.44
Disclosure

SEC source: 0001493152-23-000013 · ownership.xml · nonDerivative · entry 1

Jung Mira · CIK 0001945307 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,071,388

F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 892 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.

F2 · balance_after: Consists of 1,071,388 shares of SHPH common stock.

Read SEC document
December 29, 2022 Filed Jan 3, 2023 11:20 UTC
Dritschilo AnatolyDirector · CEO and Chairman · 10% owner
SaleCOMMON STOCK 8,372 $1.61 $13,437.06
Disclosure

SEC source: 0001493152-23-000026 · ownership.xml · nonDerivative · entry 1

Dritschilo Anatoly · CIK 0001945126 · Director · CEO and Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,085,200

F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 22,748 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.

F2 · balance_after: Consists of 1,085,200 shares of common stock held directly by the Reporting Person.

Read SEC document
December 29, 2022 Filed Jan 3, 2023 11:10 UTC
Jacobs BetteDirector
SaleCLASS A COMMON STOCK 4,366 $1.61 $7,007.43
Disclosure

SEC source: 0001493152-23-000012 · ownership.xml · nonDerivative · entry 1

Jacobs Bette · CIK 0001953668 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,221

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 11,862 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.

F2 · balance_after: Consists of 7,496 shares of SHPH common stock and 23,725 RSUs, with each RSU representing the right to receive one share of SHPH common stock upon vesting, which RSUs remain subject to certain vesting conditions.

Read SEC document
December 29, 2022 Filed Jan 4, 2023 16:10 UTC
Brown MiltonDirector
SaleCOMMON STOCK 995 $1.61 $1,596.98
Disclosure

SEC source: 0001493152-23-000318 · ownership.xml · nonDerivative · entry 1

Brown Milton · CIK 0001945206 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,072,531

F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.

F2 · balance_after: Consists of 1,072,531 shares of SHPH common stock.

Read SEC document
December 29, 2022 Filed Jan 4, 2023 21:10 UTC
Adkins WilliamFormer Director
SaleCOMMON STOCK 995 $1.61 $1,596.98
Disclosure

SEC source: 0001493152-23-000319 · ownership.xml · nonDerivative · entry 1

Adkins William · CIK 0001945434 · Former Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,071

F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.

F2 · balance_after: Consists of (i) 1,707 shares of Common Stock held by the Reporting Person and (ii) 182,364 shares of common stock held by the William Henry Adkins and Pauline Adkins 1993 Revocable Trust (the "Adkins Trust").

Read SEC document
December 29, 2022 Filed Jan 9, 2023 16:10 UTC SaleCOMMON STOCK 995 $1.61 $1,596.98
Disclosure

SEC source: 0001493152-23-000941 · ownership.xml · nonDerivative · entry 1

Richards Steven M · CIK 0001945980 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,707

F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.

F2 · balance_after: Consists of 1,707 shares of SHPH common stock.

Read SEC document
December 29, 2022 Filed Mar 14, 2024 21:02 UTC SaleCOMMON STOCK 1,626 $1.61 $2,609.73
Disclosure

SEC source: 0001493152-24-009980 · ownership.xml · nonDerivative · entry 1

Senanayake Chris · CIK 0001945766 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,791

F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 4,417 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.

F2 · balance_after: Consists of 2,791 shares of SHPH common stock.

Read SEC document
September 02, 2022 Filed Jan 4, 2023 21:10 UTC
Adkins WilliamFormer Director
OtherWARRANTS (right to buy) · Derivative 138,889 Not disclosed Strike: $4.00 Not disclosed
Disclosure

SEC source: 0001493152-23-000319 · ownership.xml · derivative · entry 2

Adkins William · CIK 0001945434 · Former Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,889

Underlying: Common Stock · 138,889 shares

Expires 2025-09-02

F3 · security: Consists of warrants to purchase 138,889 shares of common stock held by the Adkins Trust. The Adkins Trust was a holder of the Issuer's Series A convertible preferred stock, which stock converted into commons stock upon completion of the Issuer's IPO and at which time the warrants were issued to the Series A holders in accordance with the terms of the Series A preferred stock offering.

F3 · kind: Consists of warrants to purchase 138,889 shares of common stock held by the Adkins Trust. The Adkins Trust was a holder of the Issuer's Series A convertible preferred stock, which stock converted into commons stock upon completion of the Issuer's IPO and at which time the warrants were issued to the Series A holders in accordance with the terms of the Series A preferred stock offering.

F3 · price: Consists of warrants to purchase 138,889 shares of common stock held by the Adkins Trust. The Adkins Trust was a holder of the Issuer's Series A convertible preferred stock, which stock converted into commons stock upon completion of the Issuer's IPO and at which time the warrants were issued to the Series A holders in accordance with the terms of the Series A preferred stock offering.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.